Diplomat Pharmacy to offer therapy for metastatic non-small cell lung cancer
Diplomat Pharmacy Inc. on Monday announced it will offer IRESSA (gefitinib), which was recently approved by the U.S. Food and Drug Administration, as a first-line therapy for a specific type of metastatic non-small cell lung cancer. Read More »